Atorvastatin protects against cerebral ischemia/ reperfusion injury through anti-inflammatory and antioxidant effects

Neural Regeneration Research

Volumn 9, Issue 3, 2014, Pages 268-275

  Tu, Qiu Yun ^a   Cao, Hui ^b   Zhong, Wei ^b   Ding, Bin Rong ^a   Tang, Xiang Qi ^b  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Atorvastatin; Blood brain barrier; Brain injury; Cerebral ischemia reperfusion; E selectin; Free radicals; Inflammation; Malondialdehyde; Myeloperoxidase; Nerve regeneration; Neural regeneration; NSFC grant; Stroke; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; ATORVASTATIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FREE RADICAL; MALONALDEHYDE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOREACTIVITY; INFLAMMATION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; UPREGULATION;

EID: 84897869585     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.128220     Document Type: Article

References (62)

1. Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, et al. Poststroke dementia: clinical features and risk factors. Stroke. 2000; 31(7): 1494-1501.
2. Ren X, Akiyoshi K, Vandenbark AA, et al. Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke. Stroke. 2011; 42(9): 2578-2583.
3. Miyazaki T, Kimura Y, Ohata H, et al. Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion. Stroke. 2011; 42: 1097-1104.
4. DeVeber G. Arterial ischemic strokes in infants and children: an overview of current approaches. Semin Thromb Hemost. 2003; 29(6): 567-573.
5. DeVeber G. Risk factors for childhood stroke: little folks have different strokes! Ann Neurol. 2003; 53(2): 149-150.
6. Ganesan V, Prengler M, McShane MA, et al. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol. 2003; 53(2): 167-173.
7. Cao J, Xu J, Li W, et al. Influence of selective brain cooling on the expression of ICAM-1 mRNA and infiltration of PMNLs and monocytes/macrophages in rats suffering from global brain ischemia/reperfusion injury. Biosci Trends. 2008; 2(6): 241-244.
8. Wang K, Zhou X, Zhou Z, et al. Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion. Thromb Haemost. 2002; 88(1): 149-154.
9. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005; 25(6): 1102-1111.
10. Sun YX, Tang Y, Wu AL, et al. Neuroprotective effect of liquiritin against focal cerebral ischemia/reperfusion in mice via its antioxidant and antiapoptosis properties. J Asian Nat Prod Res. 2010; 12(12): 1051-1060.
11. Hua JS, Li LP, Zhu XM. Effects of moxibustion preconditioning on SOD and MDA in rats with global brain ischemia. Zhongguo Zhen Jiu. 2006; 26(8): 595-597.
12. Kim GW, Lewen A, Copin J, et al. The cytosolic antioxidant, copper/zinc superoxide dismutase, attenuates blood-brain barrier disruption and oxidative cellular injury after photothrombotic cortical ischemia in mice. Neuroscience. 2001; 105(4): 1007-1018.
13. Ding SJ, Li JS. Anti-oxidant effects of Tongxinluo on ATPase in focal brain ischemia-reperfusion rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006; 31(4): 552-555.
14. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl): 887S-968S.
15. Ganesan V. Stroke in childhood: Clinical guidelines for diagnosis, management and rehabilitation. Hosp Med. 2005; 66(1): 4-6.
16. Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008; 39(9): 2644-2691.
17. Gu WP, Xiao H, Li W, et al. Effects of atorvastatin on the expression of NF-kBp56 after cerebral ischemia/reperfusion injury in rats. Zuzhong yu Shenjing Jibing. 2007; 14(1): 3-5, 9.
18. Wu X, Lin D, Li G, et al. Statin post-treatment provides protection against simulated ischemia in bovine pulmonary arterial endothelial cells. Eur J Pharmacol. 2010; 636(1-3): 114-120.
19. Xu HC, Qian LB, Ru XC, et al. Electrophysiological effect of atorvastatin on isolated rat hearts injured by ischemia/reperfusion. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010; 39(6): 589-593.
20. Haylor JL, Harris KP, Nicholson ML, et al. Atorvastatin improving renal ischemia reperfusion injury via direct inhibition of active caspase-3 in rats. Exp Biol Med (Maywood). 2011; 236(6): 755-763.
21. Noseworthy MD, Bray TM. Effect of oxidative stress on brain damage detected by MRI and in vivo 31P-NMR. Radic Biol Med. 1998; 24(6): 942-951.
22. Feng J, Wang T, Li Q, et al. RNA interference against repulsive guidance molecule A improves axon sprout and neural function recovery of rats after MCAO/reperfusion. Exp Neurol. 2012; 238(2): 235-242.
23. Kousholt BS. Natriuretic peptides as therapy in cardiac ischaemia/reperfusion. Dan Med J. 2012; 59(6): B4469.
24. Kong Y, Rogers MR, Qin X. Effective neuroprotection by ischemic postconditioning is associated with a decreased expression of RGMa and inflammation mediators in ischemic rats. Neurochem Res. 2013; 38(4): 815-825.
25. Pan Q, Wang Z, Gao Y, et al. Eye acupuncture therapy affects intercellular adhesion molecule 1 expression in rat hippocampus of acute cerebral ischemia-reperfusion injury. Zhongguo Zuzhi Gongcheng Yanjiu. 2013; 17(37): 6636-6640.
26. Kontos HA. Oxygen radicals in cerebral ischemia: the 2001 Willis lecture. Stroke. 2001; 32(11): 2712-2716.
27. Ansari MA, Hussain SK, Mudagal MP, et al. Neuroprotective effect of allopurinol and nimesulide against cerebral ischemic reperfusion injury in diabetic rats. Eur Rev Med Pharmacol Sci. 2013; 17(2): 170-178.
28. Wang D, Yuan X, Liu T, et al. Neuroprotective activity of lavender oil on transient focal cerebral ischemia in mice. Molecules. 2012; 17(8): 9803-9817.
29. Haines BA, Mehta SL, Pratt SM, et al. Deletion of mitochondrial uncoupling protein-2 increases ischemic brain damage after transient focal ischemia by altering gene expression patterns and enhancing inflammatory cytokines. J Cereb Blood Flow Metab. 2010; 30(11): 1825-1833.
30. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010; 87(5): 779-789.
31. Benjelloun N, Renolleau S, Represa A, et al. Inflammatory responses in the cerebral cortex after ischemia in the P7 neonatal Rat. Stroke. 1999; 30(9): 1916-1923.
32. Kunz A, Dirnagl U, Mergenthaler P. Acute pathophysiological processes after ischaemic and traumatic brain injury. Best Pract Res Clin Anaesthesiol. 2010; 24(4): 495-509.
33. Ottani A, Giuliani D, Galantucci M, et al. Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism. Eur J Pharmacol. 2010; 637(1-3): 124-130.
34. Matsuo Y, Onodera H, Shiga Y, et al. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke. 1994; 25(7): 1469-1475.
35. Dong CN, Liu YC. E-selectin and ischemia-reperfusion injury in the heart. Xinxue Guan Bing Xue Jinzhan. 2006; 27(5): 637-639.
36. Strey CH, Young JM, Molyneux SL, et al. Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. Atherosclerosis. 2005; 179(1): 201-206.
37. Askalan R, Laughlin S, Mayank S, et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke. 2001; 32(6): 1257-1262.
38. Huang J, Choudhri TF, Winfree CJ, et al. Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke. 2000; 31(12): 3047-3053.
39. Frijns CJ, Kappelle LJ. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke. 2002; 33(8): 2115-2122.
40. Mueck AO, Seeger H, Wallwiener D. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules. Exp Clin Endocrinol Diabetes. 2001; 109(3): 181-183.
41. Kutlesa M, Tesovic G, Knezovic I, et al. Ischemic stroke associated with adenoviral infection in a 4-year-old boy. Wien Klin Wochenschr. 2009; 121(23-24): 776-779.
42. Lanthier S, Armstrong D, Domi T, et al. Post-varicella arteriopathy of childhood: natural history of vascular stenosis. Neurology. 2005; 64(4): 660-663.
43. Mocco J, Choudhri T, Huang J, et al. HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circ Res. 2002; 91(10): 907-914.
44. Forlow SB, White EJ, Barlow SC, et al. Severe inflammatory defect and reduced viability in CD18 and E-selectin double-mutant mice. J Clin Invest. 2000; 106(12): 1457-1466.
45. Zhou T, Chen JL, Song W, et al. Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in rats. World J Gastroenterol. 2002; 8(5): 897-900.
46. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005; 77(5): 598-625.
47. Dlamini N, Freeman JL, Mackay MT, et al. Intracranial dissection mimicking transient cerebral arteriopathy in childhood arterial ischemic stroke. J Child Neurol. 2011; 26(9): 1203-1206.
48. Braun KP, Bulder MM, Chabrier S, et al. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain. 2009; 132(Pt 2): 544-557.
49. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000; 31(6): 1283-1288.
50. Franzoni F, Quinones-Galvan A, Regoli F, et al. A comparative study of the in vitro antioxidant activity of statins. Int J Cardiol. 2003; 90(2-3): 317-321.
51. Amarenco P, Bogousslavsky J, Callahan AR, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006; 355(6): 549-559.
52. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(1): 227-276.
53. Wang LI, Mei YW, Sun ZT, et al. Changes of serum MCP-1 in patients with acute cerebral infarction and intervention effect of atorvastatin. Shanxi Yike Daxue Xuebao. 2009; 40(4): 344-346.
54. Mason RP, Walter MF, Day CA, et al. Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism. J Biol Chem. 2006; 281(14): 9337-9345.
55. Mason RP. Molecular basis of differences among statins and a comparison with antioxidant vitamins. Am J Cardiol. 2006; 98(11A): 34P-41P.
56. Cockerill GW, Huehns TY, Weerasinghe A, et al. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation. 2001; 103(1): 108-112.
57. Nofer JR, Geigenmuller S, Gopfert C, et al. High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells. Biochem Biophys Res Commun. 2003; 310(1): 98-103.
58. Jin R, Song Z, Yu S, et al. Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke. Stroke. 2011; 42(7): 2033-2044.
59. Mason RP, Walter MF, Day CA, et al. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions. Am J Cardiol. 2005; 96(5A): 11F-23F.
60. The Ministry of Science and Technology the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
61. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999; 22(9): 391-397.
62. Longa ZE, Weinstein PR. Reversible cerebral artery occlusion without eraniectomy in rats. Stroke. 1989; 20(1): 84-91.